Suk-Young Hwang
Comptroller/Controller/Auditor chez Celltrion Skincure Co., Ltd.
Postes actifs de Suk-Young Hwang
Sociétés | Poste | Début | Fin |
---|---|---|---|
Celltrion Skincure Co., Ltd.
Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Comptroller/Controller/Auditor | 29/03/2017 | - |
Historique de carrière de Suk-Young Hwang
Anciens postes connus de Suk-Young Hwang
Sociétés | Poste | Début | Fin |
---|---|---|---|
CELLTRION HEALTHCARE CO., LTD. | Comptroller/Controller/Auditor | 29/03/2016 | - |
Directeur/Membre du Conseil | 29/03/2016 | - |
Statistiques
Internationale
Corée du Sud | 3 |
Opérationnelle
Comptroller/Controller/Auditor | 2 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Celltrion Skincure Co., Ltd.
Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Healthcare Co., Ltd.
Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Bourse
- Insiders
- Suk-Young Hwang
- Expérience